• The Mirena IUD is Manufactured by Bayer...
    ...the same company that has indicated to shareholders that it will reserve an additional $262.5 million to settle Yaz and Yasmin lawsuits over blood clots
  • Call the Mirena IUD Helpline and speak to a female medical social worker and a Mirena IUD lawyer
  • The Mirena IUD has had serious complications
    • Perforation of the uterus
    • The IUD can gravitate and become embedded in the uterus or abdomen
    • Pregnancy even with the Mirena inserted
    • Gravitation of the IUD, change in position
    • Ectopic pregnancy
    • Group A streptococcal sepsis
    • Infertility when the IUD becomes embedded
    • Need for surgical removal of the Mirena
  • The Mirena IUD is a flexible intrauterine device that is placed into the uterus through the vagina by a GYN. Mirena releases a continuous dose of hormones (levonorgestrel) to prevent pregnancy for up to five years.
  • Over 2 million women in the U.S. have used Mirena IUD for birth control.
    Mirena is one of the most common IUDs currently on the market.
  • Uterine Perforation Symptoms From the Mirena: If you have these symptoms see a physician immediately.
    • Lower abdominal pain
    • Heavy vaginal bleeding
    • Inability to locate the Mirena IUD string
    • Bloating, rigidity and pain in the abdomen
    • Nausea, Vomiting, Chills, Fever, Rapid heartbeat

Posts Tagged ‘Boca raton’

Taxotere Permanent Hair Loss Lawyers

Written by Mirena IUD Helpline on . Posted in Mirena IUD Lawsuit News, Permanent Baldness medication lawyer, Taxotere Lawyer

Taxotere Permanent Hair Loss Lawsuit Helpline

Did you suffer from permanent hair loss after using Taxotere?
Did you suffer from permanent hair loss after using Taxotere?

Our Taxotere lawyers are filing lawsuits for women who will have permanent hair loss from Taxotere

A lawsuit filed in California accused the makers of a popular breast cancer chemotherapy drug of hiding side effects, including permanent hair loss, and misrepresenting the drug’s benefits.

Ami Dodson filed a lawsuit against Sanofi-Aventis, the makers of the chemotherapy drug, Taxotere (docetaxel), claiming the drug caused her to suffer permanent hair loss (alopecia). Furthermore, she said the drug maker engaged in marketing schemes to drive up the sales of the drug while hiding the medication’s increased toxicity compared to other similar drugs.

Nearly 3 million women have a history of breast cancer in the U.S. Of these women, about 75 percent were prescribed Taxotere.

“Defendants [preyed] on one of the most vulnerable group of individuals at the most difficult time in their lives,” Dodson said in her complaint. “Defendants obtained billions of dollars in increased revenues at the expense of unwary cancer victims simply hoping to survive their condition and return to a normal life.”

The U.S. Food and Drug Administration (FDA) first approved Taxotere in 1996 and by 2004, it raked in $1.4 billion each year for Sanofi. The drug is approved for use in treating a variety of cancers. In 2004, the FDA approved the drug despite significant toxicity that could cause leukemia and congestive heart failure, according to the National Cancer Institute.

Dodson claims she would not have used Taxotere if she had known it could cause permanent hair loss, especially since other less toxic options were available.

“Permanent baldness (permanent alopecia) is a disfiguring condition, especially for women,” said Dodson. “Women who experienced disfiguring permanent alopecia as a result of the use of Taxotere suffer great mental anguish as well as economic damages, including but not limited to loss of work or inability to work due to significant psychological damage.”

If you or a loved one has permanent hairloss or baldness from Taxotere call us for a Taxotere lawyer.

Talcum Powder Lawyers | Baby Powder Lawyers | Ovarian Cancer

Written by Mirena IUD Helpline on . Posted in Baby Powder lawyer, Mirena IUD Lawsuit News, Mirena Stories and Sharing, Talc ovarian cancer lawyer, Talc Ovarian Cancer Lawyers, Talcum Powder Lawyer

Talc Ovarian Cancer Lawyers

Baby Powder and Shower To Shower  Alert  for Ovarian Cancer
Studies have  linked  talcum powder to ovarian cancer.  Women are reporting ovarian cancer from years of using talc products like Johnson and Johnson Baby Powder  and Shower to Shower talc powder. The American Cancer Society estimates that in 2016, about 22,280 new cases of ovarian cancer will be diagnosed and 14,240 women will die of ovarian cancer in the United States. How many of these women will have used Talcom Powder products for years and have no idea that their ovarian cancer diagnosis is related to their use of Talc products.

Talcum Powder Lawsuit High Verdict

Johnson & Johnson (JNJ.N) was ordered to pay $72 million  to the family of a woman whose death from ovarian cancer was linked to her use of the company’s talc-based Baby Powder and Shower to Shower for several decades. A Talc victim was awarded  $10 million of actual damages and $62 million of punitive damages, according to the family’s lawyers and court records.

 

What Is Talcum Powder ?

Talcum powder is derived from talc, which is a hydrated magnesium silicate. Talcum powder is made from talc, a mineral made  of magnesium, silicon, and oxygen. It has been used by women over the years on genital areas because  it absorbs moisture and helps cut down on friction.

Dangers Of Johnson and Johnson Baby Powder and Shower To Shower  Powder

Use of  talc products over the years may increase the risk of women developing ovarian cancer. When these talc products are is applied  the talc may migrate into the fallopian tubes, uterus and ovaries resulting in cancer.

Ovarian Cancer Symptoms

Swollen or bloated abdomen.
Bloating
Pressure or pain in the abdomen or pelvis
Difficulty eating or feeling full quickly
Urinary urgency or frequency
Change in bowel habits with  constipation and/or diarrhea

Speak To A  Talcum Powder Ovarian Cancer Lawyer

Talcom Powder Ovarian Cancer Lawyers are  accepting nationwide lawsuits for  talcum powder products like Johnson’s Baby Powder and Shower-to-Shower Body Powder.

Gynecare Power Morcellator Lawyers | Power Morcellator Helpline

Written by Mirena IUD Helpline on . Posted in Birth Control Central News, Mirena IUD Lawsuit News

Gynecare Power Morcellator Lawyers Filing Lawsuits

Johnson & Johnson’s Ethicon is facing  a product liability lawsuits filed by  women diagnosed with leimoyosarcoma following a laparoscopic hysterectomy.  New studies show that the company’s Gynecare power morcellators can cause  hidden uterine cancer to be spread throughout the body.

A complaint  was filed  indicating that a female  victim  now must take oral chemotherapy to keep leiomyosarcoma cancer  from spreading  by the hysterectomy power Morcellator  from killing her.

The manufacturer failed to adequately disclose the risk of cancer following laparoscopic hysterectomy morcellation, as the device may take hidden sarcomas contained within the uterus and chop up the tissue, causing a rapid dissemination of the aggressive cancer.

Power Morcellator Lawsuit Filed

During her hysterectomy in November 2008, Davis indicates that doctors used a Gynecare morcellator to cut up the uterus through a small incision in the abdomen. However, a biopsy of the removed tissue taken during the surgery was found to contain leiomyosarcoma cancer cells, which doctors were unable to discover or diagnose before the procedure.

As a result of the leiomyosarcoma diagnosis, Davis underwent multiple cycles of chemotherapy, but by April 11, three large masses were detected in her abdomen and pelvis, confirming that the cancer had spread. She underwent additional chemotherapy and now continues to take harsh oral chemotherapy drugs.

Morcellators have become  popular for use during hysterectomy and uterine fibroid removal surgicsl procedures.  It was discovered that the Morcellators have a high risk of spreading aggressive cancer cells that may be hidden within the uterus of some women, which doctors are unable to detect or diagnose before the surgery.

Davis’s complaint is one of a growing number of laparoscopic morcellator cancer lawsuits filed against Ethicon and other manufacturers of devices sold in recent years. Each of the cases raise similar allegations, indicating that manufacturers sold a defective and unreasonably dangerous medical device, failing to warn about the link between uterine fibroid surgery and cancer.

Power Morcellator MDL

All Ethicon  power morcellator lawsuits  have been consolidated  under  District Judge Kathryn H. Vratil in the District of Kansas.

If you Have been injured by a Power Morcellator contact our new Power Morcellator Cancer Helpline.

 

Florida Testerone Lawyers

Written by Mirena IUD Helpline on . Posted in Mirena IUD Lawsuit News

Miami, Fort Lauderdale, West Palm Beach, Ft Myers, Jacksonville, Tampa , Orlando testerone  lawyers for  men who have had heart attacks or stroke while from  testosterone replacement therapy.

The FDA issued a warning on January 31, 2013 that is now re-examining the safety of testosterone gel after two studies showed a higher risk of heart attack risk and strokes in men who use them.

Miami, Fort Lauderdale and West Palm Beach Testoterone lawyers are filing lawsuits for patches, gels and injections which resulted in heart attacks or stroke.

The Products Include

Androderm injury lawyer,

AndroGel injury lawyer,

Axiron injury lawyer,

Bio-T-Gel injury lawyer,

Delatestryl injury lawyer,

Depo-Testosterone injury lawyer,

Fortesta injury lawyer,

Striant injury lawyer,

Testim injury lawyer

Testopel injury lawyer

 

It should be noted that older men with a history of heart disease were 30% more likely to suffer a stroke, heart attack or even death.

 

If you or a Miami, Fort Lauderdale, West Palm Beach loved one experienced a serious cardiovascular event  such as a heart attack or stroke after using a  replacement  product speak to an attorney in our new testosterone division.

 

 

We succeed because we consider everyday to be an opportunity to do something to help our clients – everyday people that leave their pursuit for justice in our hands.

Lawyers For Justice For Women Transvaginal Mesh Lawsuit Attorneys

Written by Mirena IUD Helpline on . Posted in Mirena IUD Lawsuit News

Transvaginal Mesh Lawyers  Declare Vaginal Mesh Complications Horrific

New Vaginal Mesh Lawsuit Department Opens

Women who have been implanted with a vaginal mesh are having complications that that are of great concern to our  mesh attorneys.

Because of the horrors of the mesh implanted in women for urinary incontinence and organ prolapse we have launched a special department to help locate women who should still be filing a vaginal mesh lawsuit. Many women are just finding out that the pain and suffering they are going thru is from the mesh implant. They are asking if they can sue the mesh manufacturers.

Yes, you can sue the manufacturers of your vaginal mesh implant in an MDL ( multi district litigation ) that has been formed under Judge Goodwin in West Virginia

We have Transvaginal mesh and bladder sling lawyers on our panel that know every step of this filing procedure and are here to help you.

Why use our Vaginal Mesh Lawyers?

Because they are lawyers experienced in drugs and devices harming women and most are female attorneys or have a a female in their office who listens and understands your situation.  If you need answers,  they have answers and in some instances can help you get a doctor for the removal of your vaginal mesh.

Call now for a local vaginal mesh attorney or a lawyer who is on top of the latest news in the MDL trials. Remember, these are centralized lawsuits. You do not need a local Vaginal mesh, TVT/TOT mesh sling or bladder sling attorney. If you are not sure if your mesh qualifies, call us now and find out.  We do not want any women with a failing Prolene mesh implant to be left out.

Mirena IUD Hopes For A Mirena Lawsuit MDL, Mirena IUD Lawsuit MDL Update

Written by Mirena IUD Helpline on . Posted in Mirena IUD Lawsuit News

The Mirena IUD Helpline receives calls daily from women with complications from the Mirena IUD. The most serious complications are perforations of the uterus, abdomen or intestines. The Mirena IUD Helpline was hoping for a consolidation of all Mirena IUD lawsuits as this makes it easier for you, the Plaintiff to file, but the manufacturer is not so happy about it.

The complications lawsuits appear to be aimed at is something called science. If the Mirena was implanted with no complications and then years later moved, gravitated or migrated and became lodged, embedded or stuck in your uterus, abdomen or intestines that is easily provable as a fault of the product based on “science”. Science appears to be an easy a equal b concept. Other complications can not as easily be equated to the IUD based on the legal concept of “science”.

Read the latest Mirena IUD News Below

Mirena IUD Helpline Keeps you Updated

Although Bayer opposes the formation of a federal MDL for the Mirena lawsuits, the drug maker did file a request to consolidate the state court Mirena litigation pending in New Jersey. However, Bayer pointed out in their recent response that the circumstances in New Jersey were unique, as all of the cases were at an early stage, with no dispositive motions pending or trial dates scheduled.

Bayer Opposes Request to Consolidate Federal Lawsuits Over Mirena IUD

Posted: 08 Feb 2013 07:30 AM PST

In response to a motion to consolidate all federal Mirena IUD lawsuits, Bayer Healthcare has filed a response opposing the centralization of the cases as part of a multi-district litigation (MDL), arguing that it would prejudice their ability to defend the safety of the implantable birth control device.

Last month, a group of plaintiffs filed a motion to establish a Mirena MDL, which would transfer all product liability lawsuits filed against Bayer over their intra-uterine contraceptive device (IUD) to one U.S. District Judge for coordinated handling during pretrial proceedings.

At that time, eight different Mirena cases filed in the federal court system were identified, with each lawsuit pending before a different judge in eight different U.S. District Courts. In addition, product liability lawyers investigating Mirena lawsuits have suggested that hundreds, if not thousands, of complaints are likely to be filed in the near future.

In a response (PDF) filed with the U.S. Judicial Panel on Multidistrict Litigation (JPML) on February 7, Bayer argued that centralization of the cases was not appropriate, and actually suggested that it would prejudice their defense by delaying the start of the first trial dates and encouraging the filing of “marginal” Mirena cases, which may require the drug maker to start negotiating Mirena settlements for business reasons, instead of legal reasons.

One of the cases identified for transfer was filed more than two years ago, and was set for trial to begin in May 2013. However, the case was stayed earlier this week pending a decision from the U.S. JPML about whether the Mirena litigation will be centralized.

Bayer argues that they would be faced with “starting over” with the MDL, which would duplicate discovery that has already been completed. The drug maker indicates that it has produced over 1.7 million pages of documents in the case and presented witnesses for depositions, suggesting that “it wants to vindicate its highly effective and currently marketed product as soon as possible.

Mirena IUD Lawsuits Involve Similar Allegations

Mirena is a T-shaped prescription intrauterine device (IUD), which is inserted into the uterus by a doctor to provide long-term birth control.

In recent weeks, a growing number of women throughout the United States have filed product liability lawsuits against Bayer alleging that they suffered severe injuries when their Mirena IUD perforated the uterus and “spontaneously” migrated following insertion.

The complaints involve common allegations that Bayer failed to adequately research the potential side effects of Mirena or warn about the risk of the IUD migrating long after it is implanted, increasing the risk of infection or serious damage to surrounding organs, often resulting in surgical removal of Mirena.

Bayer has argued that there are not sufficiently common issues of fact and law to require centralized management of the litigation, suggesting that the cases will be dominated by individual facts. The drug maker indicates that the Mirena warning label has provided information about the risk of perforation since it was introduced in 2001, so there is no need for extensive discovery about their knowledge about the risk of this complication from Mirena.

While the Mirena warning label does include information on the risk of perforation, plaintiffs argue that the language suggests that these problems only occur during insertion and that the drug maker failed to adequately warn about the risk of spontaneous migration, which may occur long after Mirena insertion. Many of the lawsuits allege that severe problems from Mirena could have been avoided if more detailed and accurate warnings had been provided.

Mirena MDL Hearing Likely in March

Consolidation of the Mirena litigation as part of an MDL, or multidistrict litigation, would result in all cases filed in U.S. District Courts throughout the country being assigned to one judge for coordinated handling in a manner similar to how a Mirena class action is managed during pretrial proceedings.

The process is designed to reduce duplicative discovery, eliminate conflicting pretrial rulings from different judges and to serve the convenience of the parties, witnesses and the courts. However, while the cases are centralized, each lawsuit remains and individual claim and if a settlement or other resolution is not reached following the MDL proceedings, each case would be remanded back to the U.S. District Court where it was originally filed for a separate trial date.

The Mirena IUD Helpline receives calls daily from women nationwide about Mirena IUD Lawsuits. “I want a Mirena IUD lawyer for a Mirena IUD lawsuit” is heard daily. Many of the complications are severe but, the ones lawyers are most interested in are Uterine and organ perforations as these are based on “science”. It appears in a lawsuit “science” means it is easy to prove. If the IUD was implanted correctly with no complications and years later migrates, moves or gravitates out of position and becomes lodged or embedded in the uterus, abdomen or intestines then it is rather straight forward. There is a long tern effect of infertility. Judges and the courts appear to look at these things in a very a equal b sort of way.

However in the hope to proceed for women injured mirena IUD lawyers were hoping to consolidate. That makes it easier for you, the plaintiff of course not enjoyed by the manufacturer that harmed you.

Ultimately, the New Jersey Supreme Court declined to centralize the Mirena cases as part of an MCL, or Multi-County Litigation. Although no details were provided by the New Jersey courts, centralized management may have been turned down because most of the New Jersey lawsuits over Mirena were already pending in one county.

It is expected that the U.S. JPML will schedule oral arguments over whether to establish a federal Mirena MDL at a hearing session scheduled to occur in San Diego, California on March 21, 2013.

 

Mirena IUD Lawsuit Moves Forward, Mirena IUD Helpline Watches

Written by Mirena IUD Helpline on . Posted in Mirena IUD Helpline, Mirena IUD Lawsuit News

The Mirena IUD Helpline , Mirena IUD lawyers,  are  watching the progress of the Mirena IUD lawsuits. ” We believe the a multi district litigation consolidation will be announced shortly. This consolidation of lawsuits under one judge in one jurisdiction will help all women file their Mirena Injury lawsuits.  As the Mirena IUD Lawsuit continues to move forward emphasis is being placed on injury where the Mirena has gravitated from the original implantation site. The device migrates and becomes embedded in the uterus or abdomen. The result is organ perforation which can lead to permanent infertility. The Mirena IUD  is surgically implanted to be effective for five years.

Mirena IUD Lawsuits are being filed by women who have  used the Mirena IUD and experienced an injury.  The Mirena IUD Lawsuit has many similarities to other mass torts currently underway. Specidic injury related to the Mirena includes: infections, dangerous scar tissue known as an adhesion,  uterine perforations, organ perforations,and infertility, abscesses, birth of a child with a birth defect, erosion of adjacent areas such as the vagina, inflammation of the membrane that lines the abdominal cavity and internal organs, intestinal perforations or obstruction, and pelvic Inflammatory Disease. There have also been some related fatalities.

Contact us today by returning the contact form or calling to discuss your specific Mirena complications with a medical social worker and get connected with a Mirena IUD lawyer.

 

 

New Bayer Mirena IUD Approved, While Mirena IUD Lawsuits Are Underway

Written by Mirena IUD Helpline on . Posted in Birth Control Central News

While women are filing lawsuits for Mirena IUD injury a new Bayer IUD is approved.  We receive calls daily from women suffering with side effects from Bayer’s Mirena IUD and yet science moves on and a new Bayer IUD is approved.

FDA Approves Bayer HealthCare (BAY)’s First New IUD in 12 Years

WAYNE, N.J., Jan. 9, 2013 /PRNewswire/ — Bayer HealthCare Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) approved Skyla (levonorgestrel-releasing intrauterine system) 13.5 mg, a new hormone-releasing system that is placed in the uterus for the prevention of pregnancy for up to three years.[1]

“Research shows that nearly 50 percent of pregnancies in the U.S. are unintended,2 which emphasizes the need for increased education and access to effective birth control options,”said Anita L. Nelson, M.D., Professor of Obstetrics and Gynecology at Harbor-UCLA Medical Center, Torrance, CA. “Skyla is more than 99 percent effective at preventing pregnancyand may be appropriate for women who want a birth control method that they do not have to take daily. Further, Skyla may be used by women whether or not they have ever had a child, representing an important new choice for women who don’t want to become pregnant for up to three years.”

Skyla is a small, flexible plastic T-shaped device containing 13.5 mg of a progestin hormone called levonorgestrel.The size of the Skyla T-body is 28mm x 30mm and the outer diameter of the placement tube is 3.8mm. Because Skyla slowly releases levonorgestrel into the uterus, only small amounts of the hormone enter the blood. During the first three to six months of using Skyla, women may experience irregular periods and an increase in the number of bleeding days. Women may also have frequent spotting or light bleeding. Some women may have heavy bleeding during this time. After using Skyla for a while, the number of bleeding and spotting days is likely to lessen, and there is a small chance that periods may stop altogether.1,3

Women can have Skyla placed by a healthcare provider during an in-office visit. Skyla is intended for long-term use for up to three years but may be removed by a healthcare provider at any time. Women could become pregnant as soon as Skyla is removed, so they should use another method of birth control if they do not want to become pregnant. About 77% of women who want to become pregnant will become pregnant sometime in the first year after Skyla is removed.3

“The approval of Skyla expands Bayer’s IUD portfolio and highlights our continued commitment to empower women with a variety of birth control options at different reproductive stages of their lives,” said Pamela A. Cyrus, M.D., Vice President and Head of U.S. Medical Affairs, Bayer HealthCare Pharmaceuticals. “We are pleased to bring the first new IUD to market in the U.S. in 12 years, and to provide women who are seeking contraception with an important new and effective option to consider with their healthcare providers.”

Skyla (levonorgestrel-releasing intrauterine system) 13.5 mg will be available by prescription the week of February 11.

About the Clinical Trial for Skyla1

The approval of Skyla is supported by data from a Phase 3 trial that included 1,432 women aged 18-35 who received Skyla, of which 38.8% (556) had not yet had a child. The trial was a multicenter, multinational, randomized open-label study conducted in 11 countries in Europe, Latin America, the U.S. and Canada. Women less than six weeks postpartum, with a history of ectopic pregnancy, with clinically significant ovarian cysts or with HIV or otherwise at high risk for sexually transmitted infections were excluded from the trial.

The pregnancy rate calculated as the Pearl Index (PI) in women aged 18-35 years was the primary efficacy endpoint used to assess contraceptive reliability. The PI was calculated based on 28-day equivalent exposure cycles; evaluable cycles excluded those in which back-up contraception was used unless a pregnancy occurred in that cycle. Skyla-treated women provided 15,763 evaluable 28-day cycle equivalents in the first year and 39,368 evaluable cycles over the three-year treatment period. The PI estimate for the first year of use based on the five pregnancies that occurred after the onset of treatment and within seven days after Skyla removal or expulsion was 0.41 with a 95% upper confidence limit of 0.96. The cumulative three-year pregnancy rate, based on 10 pregnancies, estimated by the Kaplan-Meier method was 0.9 per 100 women or 0.9%, with a 95% upper confidence limit of 1.7%.

Of Skyla-treated women, 21.9% discontinued the study treatment due to an adverse event. Most common adverse reactions (occurring in greater than or equal to 5% users) were, vulvovaginitis (20.2%), abdominal/pelvic pain (18.9%), acne/seborrhea (15.0%), ovarian cyst (13.2%), headache (12.4%), dysmenorrhea (8.6%), breast pain/discomfort (8.6%), increased bleeding (7.8%) and nausea (5.5%).

Other serious adverse reactions were also observed, including ectopic/intrauterine pregnancy, life-threatening infections, pelvic inflammatory disease (PID), perforation and expulsion.

Important Safety Information for Skyla (levonorgestrel-releasing intrauterine system) 13.5 mg

If you have a pelvic infection, get infections easily, or have certain cancers, don’t use Skyla. Less than 1% of users get a serious infection called pelvic inflammatory disease.

If you have persistent pelvic or stomach pain or if Skyla comes out, tell your doctor. If Skyla comes out, use back-up birth control. Skyla may attach to or go through the uterus and cause other problems.

Pregnancy while using Skyla is uncommon but can be life threatening and may result in loss of pregnancy or fertility. Ovarian cysts may occur but usually disappear.

Bleeding and spotting may increase in the first few months, and remain irregular. Over time, periods are likely to become shorter and lighter, or may stop.

Skyla does not protect against HIV or STDs.

Only you and your healthcare provider can decide if Skyla is right for you. Skyla is available by prescription only.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

For additional information about Skyla, please see full prescribing information at www.skyla-us.com.

About Bayer HealthCare Pharmaceuticals Inc.

Bayer HealthCare Pharmaceuticals Inc. is the U.S.-based pharmaceuticals business of Bayer HealthCare LLC, a subsidiary of Bayer AG. Bayer HealthCare is one of the world’s leading, innovative companies in the healthcare and medical products industry, and combines the activities of the Animal Health, Consumer Care, Diabetes Care, and Pharmaceuticals divisions. As a specialty pharmaceutical company, Bayer HealthCare Pharmaceuticals provides products for Diagnostic Imaging, General Medicine, Hematology, Neurology, Oncology and Women’s Healthcare. The company’s aim is to discover and manufacture products that will improve human health worldwide by diagnosing, preventing and treating diseases.

BAYER® and the Bayer Cross® are registered trademarks of Bayer. Skyla is a trademarkof Bayer.

Media Contact:

Marcy Funk,

 The Two Compared

Mirena

Initial levonorgestrel release rate is 20 mcg/day; rate reduced by 50% after 5 years

Must be removed or replaced after 5 years

Skyla

Levonorgestrel release rate is 14 mcg/day after 24 days and 5 mcg/day after 3 years

Must be removed or replaced after 3 years

 

Mirena IUD Helpline Launches Florida Mirena Outreach Campaign

Written by Mirena IUD Helpline on . Posted in Mirena IUD Lawsuit News

The Mirena IUD Helpline is beginning the national outreach campaign with the sunshine state to start this mission to locate all women with perforations  from the Mirena IUD. The devise is migrating from position and becoming lodged or embedded in the Uterus or intestines. This results in a perforation, must be surgically removed by a physicians and results in infertility.

The Mirena IUD Helpline  has a mission to locate all Florida women with severe complications from the Mirena IUD where the IUD must be surgically removed.  This expanded outreach includes the entire state of Florida and Miami, Homestead, Florida Keys, Fort Lauderdale, Boca Raton, West Palm Beach, Delray Beach, Boynton Beach, Port St Lucie, Okeechobee, Melbourne, Titusville, Daytona, Jacksonville, Ocala, Orlando, Kissimmee, Ft Myers, Winter Park, Naples, Tampa, Clearwater, St Petersburg, New Port Richey, Pensacola, Panama City, Tallahassee and all of Florida. According to the helpline MSW, “We have particular concern for  women who have had the IUD surgically removed. The result for many is permanent disability. These women are of child bearing age. The horrors of the Mirena IUD  must reach the FDA amd women must be protected.”

 

The Mirena IUD Helpline  is encouraging all women who have had a uterus perforation  to file their  Mirena IUD lawsuits. The Mirena IUD Helpline is targeting the entire state of Florida as a part of the expanded Florida campaign with hopes of locating all women with permanent injury from the Mirena IUD. It is important that women file their  Mirena lawsuits immediately.